Overview

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes
Phase:
N/A
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
University Hospitals Cleveland Medical Center
Treatments:
Clobetasol
Imiquimod